P.A. Robson

790 total citations
14 papers, 652 citations indexed

About

P.A. Robson is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Social Psychology. According to data from OpenAlex, P.A. Robson has authored 14 papers receiving a total of 652 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Cellular and Molecular Neuroscience and 4 papers in Social Psychology. Recurrent topics in P.A. Robson's work include Neuroendocrine regulation and behavior (4 papers), Neuroscience and Neuropharmacology Research (3 papers) and Receptor Mechanisms and Signaling (3 papers). P.A. Robson is often cited by papers focused on Neuroendocrine regulation and behavior (4 papers), Neuroscience and Neuropharmacology Research (3 papers) and Receptor Mechanisms and Signaling (3 papers). P.A. Robson collaborates with scholars based in France, United States and Switzerland. P.A. Robson's co-authors include S. Clements-Jewery, Christopher Yea, E. Ruuth, Robert Westwood, Jean‐Michel Bruneau, Elizabeth Kuo, Richard A. Williamson, Catherine Sautès‐Fridman, Suresh Jivan Gadher and R. Haigh and has published in prestigious journals such as Journal of Biological Chemistry, Biochemical Journal and Journal of Medicinal Chemistry.

In The Last Decade

P.A. Robson

14 papers receiving 612 citations

Peers

P.A. Robson

CMN

ONCOL

IMMUN

Brock Brown United States

Christopher Yea United Kingdom

Anders Björk Sweden

Rachel Davis‐Taber United States

Roald Ekanger Norway

Terri Cummons United States

William King United States

Zhennan Lai United States

Anita Chamba United Kingdom

John T. Garland United States

Brock Brown United States

P.A. Robson

254 ×0.8

83 ×0.9

CMN

138 ×1.8

34 ×0.5

ONCOL

94 ×1.5

IMMUN

Citations per year, relative to P.A. Robson P.A. Robson (= 1×) peers Brock Brown

Countries citing papers authored by P.A. Robson

Since Specialization

Citations

This map shows the geographic impact of P.A. Robson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P.A. Robson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P.A. Robson more than expected).

Fields of papers citing papers by P.A. Robson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P.A. Robson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P.A. Robson. The network helps show where P.A. Robson may publish in the future.

Co-authorship network of co-authors of P.A. Robson

This figure shows the co-authorship network connecting the top 25 collaborators of P.A. Robson. A scholar is included among the top collaborators of P.A. Robson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P.A. Robson. P.A. Robson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Murugesan, Nivetha, et al.. (2018). A novel oral plasma kallikrein (PKal) inhibitor KV123833 blocks VEGF-mediated retinal vascular hyperpermeability in a murine model of retinal edema. Investigative Ophthalmology & Visual Science. 59(9). 3464–3464. 3 indexed citations

Clermont, Allen C., Nivetha Murugesan, Qunfang Zhou, et al.. (2016). Plasma Kallikrein Mediates Vascular Endothelial Growth Factor–Induced Retinal Dysfunction and Thickening. Investigative Ophthalmology & Visual Science. 57(6). 2390–2390. 26 indexed citations

Yea, Christopher, Doreen M. Ashworth, James W. Barnett, et al.. (2008). New Benzylureas as a Novel Series of Potent, Nonpeptidic Vasopressin V2 Receptor Agonists. Journal of Medicinal Chemistry. 51(24). 8124–8134. 31 indexed citations

Ashworth, Doreen M., Andrew Baxter, Pierre Broqua, et al.. (2006). Nonpeptide oxytocin agonists. Drugs of the Future. 31(4). 345–345. 13 indexed citations

Haigh, R., P.A. Robson, André Tartar, et al.. (2004). Non-peptide oxytocin agonists. Bioorganic & Medicinal Chemistry Letters. 14(17). 4585–4589. 51 indexed citations

Haigh, R., P.A. Robson, André Tartar, et al.. (2004). Non‐Peptide Oxytocin Agonists.. ChemInform. 35(52). 1 indexed citations

Galyean, Robert, John Dykert, Claudio D. Schteingart, et al.. (2000). GnRH Antagonists: A New Generation of Long Acting Analogues Incorporatingp-Ureido-phenylalanines at Positions 5 and 6. Journal of Medicinal Chemistry. 44(3). 453–467. 90 indexed citations

Bruneau, Jean‐Michel, Christopher Yea, P.A. Robson, et al.. (1998). Purification of human dihydro-orotate dehydrogenase and its inhibition by A77 1726, the active metabolite of leflunomide. Biochemical Journal. 336(2). 299–303. 113 indexed citations

Curnock, Adam P., P.A. Robson, Christopher Yea, et al.. (1997). Potencies of Leflunomide and HR325 as Inhibitors of Prostaglandin Endoperoxide H Synthase-1 and -2: Comparison with Nonsteroidal Anti-Inflammatory Drugs. Journal of Pharmacology and Experimental Therapeutics. 282(1). 339–347. 14 indexed citations

10.

Williamson, R., Christopher Yea, P.A. Robson, et al.. (1996). Dihydroorotate dehydrogenase is a target for the biological effects of leflunomide.. PubMed. 28(6). 3088–91. 37 indexed citations

11.

Williamson, Richard A., Christopher Yea, P.A. Robson, et al.. (1995). Dihydroorotate Dehydrogenase Is a High Affinity Binding Protein for A77 1726 and Mediator of a Range of Biological Effects of the Immunomodulatory Compound. Journal of Biological Chemistry. 270(38). 22467–22472. 173 indexed citations

12.

Clements-Jewery, S. & P.A. Robson. (1982). Intact 5Ht neuroterminals are not required for 5HT2 receptor down-regulation by amitriptyline. Neuropharmacology. 21(7). 725–727. 30 indexed citations

13.

Clements-Jewery, S. & P.A. Robson. (1980). The in vivo and in vitro occupation of [3H]-spiperone binding sites in the frontal cortex and striatum by putative 5-hydroxytryptamine antagonists. Neuropharmacology. 19(7). 657–661. 17 indexed citations

14.

Clements-Jewery, S., et al.. (1980). Biochemical investigations into the mode of action of trazodone. Neuropharmacology. 19(12). 1165–1173. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact